ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

  • Home
  • LIVE CE Webinar! Breaking Points: Landmark Studies that Shaped Infectious Diseases Pharmacotherapy, Part 1 - Optimizing Treatment Durations

LIVE CE Webinar! Breaking Points: Landmark Studies that Shaped Infectious Diseases Pharmacotherapy, Part 1 - Optimizing Treatment Durations

  • 09 Jun 2026
  • 1:00 PM - 2:00 PM

Tuesday, June 9, 2026

12:00 pm - 1:00 pm CT/1:00 - 2:00 pm ET

Register 

Description:
Rapidly evolving literature on infectious diseases pharmacotherapy makes it challenging for pharmacists and early career physicians (and all providers) to stay familiar with the landmark trials that underpin current treatment practices. A more in-depth understanding of study designs, populations, and applicability can improve clinicians’ ability to evaluate evidence, recognize limitations, and confidently support practice changes. This webinar is the first in a series exploring landmark clinical trials, and focuses on optimization of treatment durations for infectious diseases.  

This interprofessional activity is designed for pharmacists and early career infectious diseases physicians  involved in the care of patients with infectious diseases or those who participate in antimicrobial decision-making. The content is appropriate for clinicians practicing in inpatient, outpatient, or transitional care settings who seek to enhance their ability to interpret landmark trials and apply evidence-based pharmacotherapy in practice.

Agenda:
Following introductions, speakers will discuss four clinical trials with active learning occurring throughout. The session will end with attendee Q&A.

Target Audience: 
An interprofessional audience, specifically pharmacists and early career infectious diseases physicians.


Learning Objectives
:
  • Analyze applicability and limitations of landmark trials in infectious diseases pharmacotherapy for the treatment of durations in real-world practice
  • Describe how findings from landmark trials are adopted or challenged and the barriers to application in practice as related to treatment durations
  • Apply practical strategies to help interprofessional teams implement evidence-based practices for treatment durations from landmark studies

Faculty:

Allan M. Seibert, MD, AAHIVS
Attending Physician, Assistant Professor 
Division of Infectious Diseases, Antimicrobial Stewardship
Intermountain Health
Murray, UT

Nicholas Tinker, PharmD, BCIDP
Antimicrobial Stewardship Pharmacist
Telehealth Infectious Diseases
Intermountain Health
Broomfield,CO


Accreditation:

Pharmacist 

The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

UAN: 0672-0000-26-029-L01-P
CPE credit: 1.0 contact hour (0.1 CEU)
Type of activity: Application
Release date:June 9, 2026
ACPE Activity Fee: SIDP Member: Free / Non-Member: $10

To receive CE credit, participants must view the CE content, complete a post-test, and complete an evaluation. Proof of completion will be submitted to NABP CPE Monitor.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Participants are responsible for verifying credits were transferred successfully to your NABP eProfile account before the ACPE 60-day deadline. After the 60 day deadline, SIDP will no longer be able to report your credit(s) for this activity.

Funding:  This activity is provided by SIDP. No external funding was received for this activity.

Disclosures:   In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, SIDP asks all individuals involved in the development and presentation of CE activities to disclose all financial relationships with ineligible companies. All relevant financial relationships have been mitigated prior to the CE activity. The following financial relationships have been disclosed:

  • Dr. Seibert and Dr. Tinker have no relevant financial relationships with an ineligible company to disclose.
  • Presentation title and objectives were written by the planning committee and enhanced by AI. All enhancements were reviewed by a human. 

Disclaimer:   Faculty members are asked to disclose when any unlabeled/investigational use of pharmaceuticals and devices is being discussed. This activity is intended for educational purposes and should not be used as a substitute for care or advice from a professional. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SIDP.

The planners and faculty of this continuing education activity have made all reasonable efforts to ensure the accuracy of the information presented in accordance with the latest available scientific knowledge at the time of publication. Healthcare professionals should verify all information and data with recommendations of other authorities before treating patients or employing any therapies described in this continuing education activity.



Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software